Download PDF
Thromb Haemost 1995; 74(06): 1428-1431
DOI: 10.1055/s-0038-1649959
Original Articles
Clinical Studies
Schattauer GmbH Stuttgart

Subcutaneous Low-Molecular Weight Heparin or Oral Anticoagulants for the Prevention of Deep-Vein Thrombosis in Elective Hip and Knee Replacement?

Karly Hamulyák
1   The Department of Haematology, University Hospital of Maastricht, Maassluis, The Netherlands
,
Anthonie W A Lensing
2   The Centre for Haemostasis, Thrombosis, Atherosclerosis, and Inflammation Research, Academic Medical Centre, Amsterdam, The Netherlands
,
Jan van der Meer
3   The Department of Haemostasis, Thrombosis and Rheology, University Hospital of Groningen, Maassluis, The Netherlands
,
Willem M Smid
5   Trial Coordination Centre, University Hospital of Groningen, Maassluis, The Netherlands
,
André van Ooy
4   The Department of Orthopaedics, University Hospital of Maastricht, Maassluis, The Netherlands
,
Jaap A Hoek
6   The Clinical Research Department, Sanofi Winthrop, Maassluis, The Netherlands
,
for the Fraxiparine Oral Anticoagulant Study Group › Author Affiliations
Further Information

Publication History

Received: 17 May 1995

Accepted after revision 01 August 1995

Publication Date:
10 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

Objective. To compare efficacy, safety, and feasibility of adjusted- dose oral anticoagulants (OAC) versus fixed-dose subcutaneous low molecular weight heparin (LMWH) for the prevention of deep venous thrombosis (DVT) in patients who have undergone elective hip or knee replacement.

Design. Multicentre, single blind randomised trial. OAC (acenocoumarol, target International Normalised Ratio, 2.0-3.0) and LMWH (nadroparine, 60 aXa IU/kg once daily) were started preoperatively and continued for 10 days. All outcome measures were adjudicated by an independent committee unaware of treatment allocation.

Subjects. 672 consecutive patients scheduled for elective hip or knee replacement surgery. All patients wore bilateral graduated compression stockings.

Main outcome measures. The endpoint for the assessment of efficacy was venography confirmed DVT or confirmed symptomatic pulmonary embolism. The endpoint for the assesment of safety was clinically important bleeding during study treatment or within 48 h of the end of treatment.

Results. Among the 517 patients with interpretable venograms, 391 had a hip replacement and 126 had a knee implant. DVT was demonstrated in 50 (20%) of 257 patients allocated to OAC and 43 (17%) of 260 patients allocated to nadroparine (p = 0.45), for an absolute difference in DVT incidence of 2.9% in favour of nadroparine (95% Cl, -3.7-9.5). Clinically important bleeding occurred in eight (2.3%) of the 342 oral anticoagulant treated patients and in five (1.5%) of the 330 nadroparine treated patients (p = 0.62), for an absolute difference in favour of nadroparine of 0.8% (95% Cl, -1.3-2.9).

Conclusion. Patients who undergo major orthopaedic operations have a high risk of venous thromboembolism. Once daily fixed-dose subcutaneous nadroparine is at least as efficacious and safe as daily adjusted OAC for prophylaxis against DVT after hip or knee implantation but is more simple to administer.

 

  • References

  • 1 Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. N Engl J Med 1988; 318: 1162-1173
    CrossrefPubMedGoogle Scholar
  • 2 Leyvraz PF, Richard J, Bachmann F. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep vein thrombosis after total hip replacement. N Engl J Med 1983; 309: 954-958
    CrossrefPubMedGoogle Scholar
  • 3 Francis CW, Marder VJ, Evarts CM, Yaukoolbodi S. Two-step warfarin therapy: prevention of postoperative venous thrombosis without excessive bleeding. JAMA 1983; 249: 374-378
    CrossrefPubMedGoogle Scholar
  • 4 Harris WH, Athanasoulis CA, Waltman AC, Sakman EW. Prophylaxis of deep-vein thrombosis after total hip replacement. J Bone Joint Surgery 1985; 67: 57-62
    PubMedGoogle Scholar
  • 5 Clagett GP, Anderson Jr FA, Levine MN, Salzman EW, Wheeler HB. Prevention of venous thromboembolism. Chest 1992; 102 suppl 391S-407S
    CrossrefPubMedGoogle Scholar
  • 6 Gallus A, Raman K, Darby T. Venous thrombosis after elective hip replacement: the influence of preventive intermittent calf compression and of surgical technique. Br J Surg 1983; 70: 17-19
    CrossrefPubMedGoogle Scholar
  • 7 Hull RD, Raskob GE, Gent M, McLoughlin D, Julian D, Smith FC, Dale NI, Reeds-Davis R, Lofthouse RN, Anderson C. Effectiveness of intermittent pneumatic leg compression for preventing deep vein thrombosis after total hip replacement. JAMA 1990; 263: 2313-2317
    CrossrefPubMedGoogle Scholar
  • 8 Prevention of venous thrombosis and pulmonary embolism. NIH Consensus Development. JAMA 1986; 256: 744-749
    CrossrefPubMedGoogle Scholar
  • 9 Hirsh J. From unlractionated heparins to low molecular weight heparins. Ada Cliir Seaiul 1990; (Suppl. 556) suppl 42-50
    PubMedGoogle Scholar
  • 10 Hirsh J, Levine MN. Low molecular weight heparin. Blood 1992; 79: 1-18
    PubMedGoogle Scholar
  • 11 Nurmohamed MT, Rosendaal FR, Büller HR, Dekker E, Homines DW, Vamlenbroucke JP, ten Cate JW. Low-molecular weight heparin versus standard heparin in general and orthopedic surgery: a meta analysis. Lancet 1992; 340: 152-156
    CrossrefPubMedGoogle Scholar
  • 12 Prandoni P, Lensing AW A, Büller HR, Carta MR, Cogo A, Vigo M, Casara D, Ruol A, ten Cate JW. Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis. Lancet 1992; 339: 441-445
    CrossrefPubMedGoogle Scholar
  • 13 Hull RD, Raskob GL, Pineo GF, Green D, Trowbridge AA, Elliot CG, Lerner RG, Hall J, Sparling T, Brettel HR, Norton J, Carter CJ, George R, Merli G, Ward J, Mayo W, Rosenbloom D, Brant R. Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis. N Engl J Med 1992; 326: 975-982
    CrossrefPubMedGoogle Scholar
  • 14 Lensing AW A, Prins M, Koopman MM W, Biiller HR. Which heparin for proximal deep-vein thrombosis. Lancet 1992; 340: 311-312
    PubMedGoogle Scholar
  • 15 Anderson DR, O’Brien BJ, Levine MN, Roberts R, Wells PS, Hirsh J. Efficacy and cost of low molecular weight heparin compared with standard heparin for the prevention of deep vein thrombosis after total hip arthroplasty. Ann Intern Med 1993; 119: 1105-1112
    CrossrefPubMedGoogle Scholar
  • 16 Hull RD, Raskob G, Pineo G, Rosenbloom D, Evans W, Mallory T, Anquist K, Smith F, Hughes G, Green D, Elliot CG, Panju A, Brant R. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med 1993; 329: 1370-1376
    CrossrefPubMedGoogle Scholar
  • 17 RD Heparin Arthroplasty group. RD heparin compared with warfarin for prevention of venous thromboembolic disease following total hip or knee arthroplasty. J Bone Joint Surg 1994; 76 A 1174-1185
    CrossrefPubMedGoogle Scholar
  • 18 Hull RD, Hirsh J, Carter CJ, Raskob GE, Gill GJ, Jay RM, Leclerq JR, David M, Coates G. Diagnostic value of ventilation-perfusion lung scanning in patients with suspected pulmonary embolism. Chest 1985; 88: 819-828
    CrossrefPubMedGoogle Scholar
  • 19 PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism: results of the Prospective Investigation of Pulmonary Embolism diagnosis (PIOPED). JAMA 1990; 263: 2753-2759
    CrossrefPubMedGoogle Scholar
  • 20 Bookstein JJ, Silver TM. The angiographic differential diagnosis of acute pulmonary embolism. Radiology 1974; 110: 25-33
    CrossrefPubMedGoogle Scholar
  • 21 Lensing AW A, Hirsh J, Büller HR. Diagnosis of venous thrombosis. In: Hemostasis and thrombosis: basic principles and clinical practice. 3rd ed. Colman RW, Hirsh J, Marder VJ, Salzman EW. eds. Philadelphia; JB LippincottCo: 1994: 1297-1321
    Google Scholar
  • 22 Jongbloets LM M, Lensing AW A, Büller HR, ten Cate JW. The distribution of calf vein thrombosis in asymptomatic postoperative patients and its implications for screening with ultrasonography. Thromb Res 1992; 65 suppl C 87
    PubMedGoogle Scholar
  • 23 Wells PS, Lensing AW A, Hirsh J. Graduated compression stockings in the prevention of postoperative venous thromboembolism. Arch Intern Med 1994; 154: 67-72
    CrossrefPubMedGoogle Scholar
  • 24 Wells PS, Lensing AW A, Davidson BL, Prins MH, Hirsh J. Accuracy of ultrasound for the diagnosis of deep venous thrombosis in asymptomatic patients after orthopedic surgery. Ann Intern Med 1995; 122: 47-53
    CrossrefPubMedGoogle Scholar
  • 25 Davidson BL, Elliott CG, Lensing AW A. Low accuracy of color Doppler ultrasound in the detection of proximal leg vein thrombosis in asymptomatic high-risk patients. Ann Intern Med 1992; 117: 735-738
    CrossrefPubMedGoogle Scholar
  • 26 Jongbloets LM M, Lensing AW A, Koopman MM W, Büller HR, ten Cate JW. Limitations of compression ultrasound imaging for the detection of symptomless postoperative deep vein thrombosis. Lancet 1994; 343: 1142-1144
    CrossrefPubMedGoogle Scholar
  • 27 Bergqvist D. Long-term prophylaxis following orthopedic surgery. Haemostasis 1994; 23 suppl (Suppl. 01) 27-31
    PubMedGoogle Scholar